BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,071,208 | -19.8% | 160,717 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $10,060,113 | -31.7% | 159,179 | -51.4% | 0.00% | -33.3% |
Q1 2023 | $14,732,201 | +18.6% | 327,455 | +15.5% | 0.00% | +50.0% |
Q4 2022 | $12,425,480 | -51.9% | 283,622 | -27.6% | 0.00% | -66.7% |
Q3 2022 | $25,821,000 | +105.7% | 391,887 | +57.7% | 0.01% | +100.0% |
Q2 2022 | $12,554,000 | -56.8% | 248,559 | -45.4% | 0.00% | -50.0% |
Q1 2022 | $29,081,000 | +158.0% | 455,239 | +332.7% | 0.01% | +200.0% |
Q4 2021 | $11,270,000 | +823.8% | 105,214 | +786.2% | 0.00% | – |
Q3 2021 | $1,220,000 | -13.3% | 11,873 | -25.8% | 0.00% | – |
Q2 2021 | $1,407,000 | -20.5% | 15,993 | -12.1% | 0.00% | – |
Q1 2021 | $1,770,000 | -68.5% | 18,200 | -63.7% | 0.00% | -100.0% |
Q4 2020 | $5,619,000 | -40.9% | 50,103 | -51.1% | 0.00% | -33.3% |
Q3 2020 | $9,502,000 | -73.9% | 102,491 | -78.0% | 0.00% | -76.9% |
Q2 2020 | $36,404,000 | +25.2% | 466,710 | -6.1% | 0.01% | 0.0% |
Q1 2020 | $29,080,000 | +171.8% | 497,267 | +272.3% | 0.01% | +225.0% |
Q4 2019 | $10,699,000 | -38.9% | 133,559 | -44.0% | 0.00% | -55.6% |
Q3 2019 | $17,519,000 | +102.4% | 238,443 | +159.8% | 0.01% | +125.0% |
Q2 2019 | $8,656,000 | -5.2% | 91,764 | -19.6% | 0.00% | 0.0% |
Q1 2019 | $9,132,000 | +226.5% | 114,090 | +119.9% | 0.00% | +300.0% |
Q4 2018 | $2,797,000 | -86.6% | 51,889 | -80.6% | 0.00% | -90.0% |
Q3 2018 | $20,898,000 | +236.6% | 267,709 | +173.7% | 0.01% | +233.3% |
Q2 2018 | $6,208,000 | +24.2% | 97,795 | +79.4% | 0.00% | 0.0% |
Q1 2018 | $4,999,000 | -24.9% | 54,516 | -38.2% | 0.00% | -25.0% |
Q4 2017 | $6,656,000 | +114.2% | 88,258 | +97.9% | 0.00% | +33.3% |
Q3 2017 | $3,107,000 | -82.6% | 44,600 | -87.3% | 0.00% | -80.0% |
Q2 2017 | $17,809,000 | +134.7% | 351,482 | +85.2% | 0.02% | +150.0% |
Q1 2017 | $7,589,000 | +262.1% | 189,774 | +154.0% | 0.01% | +200.0% |
Q4 2016 | $2,096,000 | +278.3% | 74,711 | +300.6% | 0.00% | +100.0% |
Q3 2016 | $554,000 | -84.7% | 18,650 | -86.4% | 0.00% | -75.0% |
Q4 2015 | $3,617,000 | -69.0% | 137,303 | -74.9% | 0.00% | -63.6% |
Q3 2015 | $11,673,000 | -35.5% | 546,991 | -20.0% | 0.01% | -31.2% |
Q2 2015 | $18,108,000 | – | 683,584 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |